knowledge
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: ProMED sees offers of support, but its future remains unclear
Next article: ProMED sees offers of support, but its future remains unclear
entertainment
leisure time
-
ActiGraph execs on goal of drug approvals with digital endpoints
2025-09-30 04:34 -
Eye stem cell transplant could help restore vision in injured people
2025-09-30 04:06 -
Neuroscience startup Neumora files for IPO
2025-09-30 04:00 -
Clinical trials must include more disabled people
2025-09-30 03:41 -
How Long Island became the ‘eugenics capital of the world’
2025-09-30 03:40 -
Drug firms test therapies to halt Alzheimer’s before symptoms arise
2025-09-30 03:19